EU funds new research into psychedelic therapy for palliative care patients

26 Jan 2024 — The PsyPal clinical trial coordinated by the University Medical Center Groningen (UMCG) in the Netherlands, in collaboration with HumanKindLabs, will receive full funding from the EU’s Horizon Europe program for scientific research. PsyPal is set to explore the therapeutic potential of psilocybin therapy for patients experiencing psychological distress in the face of disease.